Evidence map›Paper›PMID 29921728›Full record

ArticleOccupational and environmental medicine2018

Night work and prostate cancer risk: results from the EPICAP Study.

Méyomo Gaelle Wendeu-Foyet, Virginie Bayon, Sylvie Cénée, Brigitte Trétarre, Xavier Rébillard, Géraldine Cancel-Tassin, Olivier Cussenot, Pierre-Jean Lamy, Brice Faraut, Soumaya Ben Khedher and 2 more

Abstract read
In one paragraph

Article in Occupational and environmental medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2020
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Circadian rhythm disruption and endocrine-related tumors.World journal of clinical oncology · 2024
    Review
  9. Article
  10. Review
  11. Co-delivery of Siape1 and Melatonin byRecent patents on anti-cancer drug discovery · 2024
    Article
  12. Association between Outdoor Light at Night and Prostate Cancer in the Health Professionals Follow-up Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Occupation and prostate Cancer risk: results from the epidemiological study of prostate cancer (EPICAP).Journal of occupational medicine and toxicology (London, England) · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Méyomo Gaelle Wendeu-FoyetTeam Cancer and Environment, Université Paris-Saclay, Université Paris-Sud, CESP (Center for Research in Epidemiology and Population Health), Inserm, Villejuif, France.
Virginie BayonCentre du sommeil et de la vigilance, Hôtel Dieu, APHP, Paris, France.
Sylvie CénéeTeam Cancer and Environment, Université Paris-Saclay, Université Paris-Sud, CESP (Center for Research in Epidemiology and Population Health), Inserm, Villejuif, France.
Brigitte TrétarreHérault Cancer Registry, EA 2415, ICM, Montpellier, France.
Xavier RébillardClinique Beau Soleil, Montpellier, France.
Géraldine Cancel-TassinCeRePP, Hopital Tenon, Paris, France.
Olivier CussenotCeRePP, Hopital Tenon, Paris, France.
Pierre-Jean LamyClinique Beau Soleil, Montpellier, France.
Brice FarautCentre du sommeil et de la vigilance, Hôtel Dieu, APHP, Paris, France.
Soumaya Ben KhedherTeam Cancer and Environment, Université Paris-Saclay, Université Paris-Sud, CESP (Center for Research in Epidemiology and Population Health), Inserm, Villejuif, France.
Damien LégerCentre du sommeil et de la vigilance, Hôtel Dieu, APHP, Paris, France.
Florence MenegauxTeam Cancer and Environment, Université Paris-Saclay, Université Paris-Sud, CESP (Center for Research in Epidemiology and Population Health), Inserm, Villejuif, France.ORCID 0000-0003-3363-6411

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the role of night work in prostate cancer based on data from the EPICAP Study.

methodsEPICAP is a French population-based case-control study including 818 incident prostate cancer cases and 875 frequency-matched controls that have been interviewed face to face on several potential risk factors including lifetime occupational history. Detailed information on work schedules for each job (permanent or rotating night work, duration, total number of nights, length of the shift, number of consecutive nights) as well as sleep duration and chronotype, was gathered. Prostate cancer aggressiveness was assessed by Gleason Score.

resultsNight work was not associated with prostate cancer, whatever the aggressiveness of prostate cancer, while we observed an overall increased risk among men with an evening chronotype (OR=1.83, 95% CI 1.05 to 3.19). A long duration of at least 20 years of permanent night work was associated with aggressive prostate cancer (OR=1.76, 95% CI 1.13 to 2.75), even more pronounced in combination with a shift length >10 hours or ≥ 6 consecutive nights (OR=4.64, 95% CI 1.78 to 12.13; OR=2.43, 95% CI 1.32 to 4.47, respectively).

conclusionOverall, ever night work, either permanent or rotating, was not associated to prostate cancer. Nevertheless, our results suggest that a long duration of permanent night work in combination with a long shift length or at least six consecutive nights may be associated with prostate cancer, particularly with aggressive prostate cancer. Further studies are needed to confirm those findings.

Indexed as

AgedCase-Control StudiesCircadian RhythmEmploymentFranceHumansMaleMiddle AgedNeoplasm GradingOccupational DiseasesOccupational ExposureOdds RatioProstatic NeoplasmsRisk FactorsSeverity of Illness IndexSleepCancerEpidemiologyShift Work

Identifiers

PMID29921728
PMCPMC6204930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.